Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It is one of the most studied dual-incretin peptides in contemporary metabolic research.
**Vial contents:** 10mg Tirzepatide lyophilized
**Purity:** >99% HPLC verified
**Storage:** -20°C lyophilized; 2–8°C reconstituted
**COA:** Third-party tested, included
**Research use only. Not for human consumption.**
Reviews
There are no reviews yet.